📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
This new @eortc.org #HRQoL questionnaire was developed to better capture these realities 👇
www.eortc.org/blog/2026/01...
#GivingVoice2Patients
@sotonhsciences.bsky.social
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
This new @eortc.org #HRQoL questionnaire was developed to better capture these realities 👇
www.eortc.org/blog/2026/01...
#GivingVoice2Patients
@sotonhsciences.bsky.social
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
Join our webinar with OAC & @qol.eortc.org to explore why listening to patients, especially older adults, matters.
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 Registration soon: www.eortc.org/event/joint-...
#CancerCare #OlderAdults
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 More info: www.eortc.org/event/joint-...
#CancerResearch #ClinicalTrials
Join us on 9 January 2026 for the EORTC webinar Patient Preferences Matter.
🔗 Register here: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 More info: www.eortc.org/event/joint-...
#CancerResearch #ClinicalTrials
A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟
📰 Access the paper: doi.org/10.1186/s128...
#GivingVoice2Patients #CancerResearch
@miekevhr.bsky.social
A new international study validates the @eortc.org #QualityofLife PATSAT-C33 & OUT-PATSAT7 questionnaires as robust tools for measuring patient satisfaction in cancer care. 🌟
📰 Access the paper: doi.org/10.1186/s128...
#GivingVoice2Patients #CancerResearch
@miekevhr.bsky.social
Your generosity powers smarter, fairer cancer research.
Donate: donate.eortcresearchfund.org/eoy/~my-dona...
🎥Watch & see why your support matters: youtu.be/QzQ2_CnwpDM
#ECRF
Your generosity powers smarter, fairer cancer research.
Donate: donate.eortcresearchfund.org/eoy/~my-dona...
🎥Watch & see why your support matters: youtu.be/QzQ2_CnwpDM
#ECRF
Our @qol.eortc.org experts Lotte Van der Weijst & @miekevhr.bsky.social shared insights on EORTC advances in QoL&mental health assessment👇
health.ec.europa.eu/non-communic...
Our @qol.eortc.org experts Lotte Van der Weijst & @miekevhr.bsky.social shared insights on EORTC advances in QoL&mental health assessment👇
health.ec.europa.eu/non-communic...
📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11...
#QualityofLife #GivingVoice2Patients
@eortc.org
🔗 Read more in our press release: www.eortc.org/blog/2025/11...
#CancerResearch @qol.eortc.org @thelancet.com
📰 More about the new SISAQOL-IMI publication & online resources: www.eortc.org/blog/2025/11...
#QualityofLife #GivingVoice2Patients
@eortc.org
@europeancancer.bsky.social
@europeancancer.bsky.social
www.soc-neuro-onc.org/SNO2025
#NeuroOncology @neuroonc.bsky.social
www.soc-neuro-onc.org/SNO2025
#NeuroOncology @neuroonc.bsky.social
#EuropeanCancerSummit #CancerResearch
#EuropeanCancerSummit #CancerResearch
#QualityofLife #GivingVoice2Patients #CancerResearch
@eortc.org
🎥 For more info about SISAQOL-IMI, watch the video: youtu.be/tjuoyTuClPQ?...
@qol.eortc.org
#QualityofLife #GivingVoice2Patients #CancerResearch
@eortc.org
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
More info 👇
#GivingVoice2Patients
More info 👇
#GivingVoice2Patients
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
🎖️ And it was selected as one of the best abstracts 👏
www.jahrestagung-haematologie-onkologie.com
#GivingVoice2Patients #DGHO #CancerResearch
🎖️ And it was selected as one of the best abstracts 👏
www.jahrestagung-haematologie-onkologie.com
#GivingVoice2Patients #DGHO #CancerResearch
🔍 Learn more: www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
🔍 Learn more: www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology
Read more ➡️ www.eortc.org/blog/2025/10...
#QualityofLife #GivingVoice2Patients #CancerResearch
📅 Thurs 23 Oct, 13:50 CT, Session 102: Hematology
Read more ➡️ www.eortc.org/blog/2025/10...
#QualityofLife #GivingVoice2Patients #CancerResearch
Learn more 👇
www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
Learn more 👇
www.eortc.org/blog/2025/10...
#GivingVoice2Patients #CancerResearch
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social
📢 Catch tomorrow's presentation by @eortc.org #QualityofLife Group (QLG) member Anne-Sophie Darlington about a new EORTC QLG questionnaire aimed to measure all QoL issues of relevance and importance to AYAs aged 14-39 years with cancer.
@worldsiop.bsky.social